These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33799989)

  • 1. Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer.
    Sugimura-Nagata A; Koshino A; Inoue S; Matsuo-Nagano A; Komura M; Riku M; Ito H; Inoko A; Murakami H; Ebi M; Ogasawara N; Tsuzuki T; Takahashi S; Kasugai K; Kasai K; Inaguma S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis.
    Yang H; Shao R; Huang H; Wang X; Rong Z; Lin Y
    Cancer Med; 2019 Aug; 8(9):4245-4253. PubMed ID: 31183992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma.
    Tang XX; Shimada H; Ikegaki N
    Curr Oncol; 2024 Jun; 31(6):3212-3226. PubMed ID: 38920727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD47 expression and CD163
    Imam R; Chang Q; Black M; Yu C; Cao W
    BMC Cancer; 2021 Mar; 21(1):320. PubMed ID: 33765961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.
    Sakakura K; Takahashi H; Kaira K; Toyoda M; Murata T; Ohnishi H; Oyama T; Chikamatsu K
    Lab Invest; 2016 Sep; 96(9):994-1003. PubMed ID: 27322955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis.
    Zhang W; Huang Q; Xiao W; Zhao Y; Pi J; Xu H; Zhao H; Xu J; Evans CE; Jin H
    Front Immunol; 2020; 11():18. PubMed ID: 32082311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
    Willingham SB; Volkmer JP; Gentles AJ; Sahoo D; Dalerba P; Mitra SS; Wang J; Contreras-Trujillo H; Martin R; Cohen JD; Lovelace P; Scheeren FA; Chao MP; Weiskopf K; Tang C; Volkmer AK; Naik TJ; Storm TA; Mosley AR; Edris B; Schmid SM; Sun CK; Chua MS; Murillo O; Rajendran P; Cha AC; Chin RK; Kim D; Adorno M; Raveh T; Tseng D; Jaiswal S; Enger PØ; Steinberg GK; Li G; So SK; Majeti R; Harsh GR; van de Rijn M; Teng NN; Sunwoo JB; Alizadeh AA; Clarke MF; Weissman IL
    Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6662-7. PubMed ID: 22451913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of colorectal cancer by hierarchical clustering analyses of five immune cell markers.
    Ito S; Koshino A; Komura M; Kato S; Otani T; Wang C; Ueki A; Takahashi H; Ebi M; Ogasawara N; Tsuzuki T; Kasai K; Kasugai K; Takiguchi S; Takahashi S; Inaguma S
    Pathol Int; 2024 Jan; 74(1):13-25. PubMed ID: 38050808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47-SIRP
    Catalán R; Orozco-Morales M; Hernández-Pedro NY; Guijosa A; Colín-González AL; Ávila-Moreno F; Arrieta O
    J Immunol Res; 2020; 2020():9435030. PubMed ID: 33015199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated CD163
    Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
    Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
    [No Abstract]   [Full Text] [Related]  

  • 12. CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis.
    Morrissey MA; Kern N; Vale RD
    Immunity; 2020 Aug; 53(2):290-302.e6. PubMed ID: 32768386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
    Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
    Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
    Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
    Front Immunol; 2021; 12():679090. PubMed ID: 34054869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
    Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
    Front Immunol; 2021; 12():724429. PubMed ID: 34512652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPα in adult T-cell leukemia/lymphoma.
    Yanagida E; Miyoshi H; Takeuchi M; Yoshida N; Nakashima K; Yamada K; Umeno T; Shimasaki Y; Furuta T; Seto M; Ohshima K
    Hematol Oncol; 2020 Dec; 38(5):680-688. PubMed ID: 32569413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial distribution of tumor-resident macrophages as predictive biomarkers in endometrial cancer.
    Matsukawa T; Yoshikawa N; Liu W; Hattori S; Yoshida K; Yoshihara M; Tamauchi S; Yokoi A; Niimi K; Kajiyama H
    J Obstet Gynaecol Res; 2024 Jul; 50(7):1141-1147. PubMed ID: 38627199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunotherapy targeting the CD47/SIRPα axis.
    Weiskopf K
    Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes.
    Sharp RC; Brown ME; Shapiro MR; Posgai AL; Brusko TM
    Front Immunol; 2021; 12():739048. PubMed ID: 34603322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of CD47 and signal-regulatory protein-α constituting the "don't eat me signal" is a prognostic factor in diffuse large B-cell lymphoma.
    Kazama R; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yoshida N; Kawamoto K; Yanagida E; Yamada K; Umeno T; Suzuki T; Kato K; Takizawa J; Seto M; Akashi K; Ohshima K
    Cancer Sci; 2020 Jul; 111(7):2608-2619. PubMed ID: 32342603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.